AU2001270484A1 - Use of bradycardiac substances in the treatment of myocardial diseases associated with hypertrophy and novel medicament combinations - Google Patents

Use of bradycardiac substances in the treatment of myocardial diseases associated with hypertrophy and novel medicament combinations

Info

Publication number: AU2001270484A1
Authority: AU; Australia
Prior art keywords: hypertrophy; treatment; diseases associated; myocardial diseases; medicament combinations
Prior art date: 2000-04-13
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

AU2001270484A

Other versions

AU2001270484B2 (en

Inventor

Jurgen Dammgen

Brian Guth

Randolph Seidler

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Boehringer Ingelheim Pharma GmbH and Co KG

Original Assignee

Boehringer Ingelheim Pharma GmbH and Co KG

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-04-13

Filing date

2001-04-07

Publication date

2002-01-17

2000-04-13 Priority claimed from DE10018401A external-priority patent/DE10018401A1/en

2001-04-07 Application filed by Boehringer Ingelheim Pharma GmbH and Co KG filed Critical Boehringer Ingelheim Pharma GmbH and Co KG

2002-01-17 Publication of AU2001270484A1 publication Critical patent/AU2001270484A1/en

2004-05-13 Assigned to BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG reassignment BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG Amend patent request/document other than specification (104) Assignors: BOEHRINGER INGELHEIM PHARMA KG

2007-01-25 Application granted granted Critical

2007-01-25 Publication of AU2001270484B2 publication Critical patent/AU2001270484B2/en

2021-04-07 Anticipated expiration legal-status Critical

Status Ceased legal-status Critical Current

Links

AU2001270484A 2000-04-13 2001-04-07 Use of bradycardiac substances in the treatment of myocardial diseases associated with hypertrophy and novel medicament combinations Ceased AU2001270484B2 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
DE10018401.4		2000-04-13
DE10018401A DE10018401A1 (en)	2000-04-13	2000-04-13	Medicament for treating hypertrophy-related myocardial disease, containing bradycardic agent, preferably cilobradine, and optionally another cardiac drug
PCT/EP2001/004034 WO2001078699A2 (en)	2000-04-13	2001-04-07	Use of bradycardiac substances in the treatment of myocardial diseases associated with hypertrophy and novel medicament combinations

Publications (2)

Publication Number	Publication Date
AU2001270484A1 true AU2001270484A1 (en)	2002-01-17
AU2001270484B2 AU2001270484B2 (en)	2007-01-25

Family

ID=7638652

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
AU7048401A Pending AU7048401A (en)	2000-04-13	2001-04-07	Use of bradycardiac substances in the treatment of myocardial diseases associated with hypertrophy and novel medicament combinations
AU2001270484A Ceased AU2001270484B2 (en)	2000-04-13	2001-04-07	Use of bradycardiac substances in the treatment of myocardial diseases associated with hypertrophy and novel medicament combinations

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
AU7048401A Pending AU7048401A (en)	2000-04-13	2001-04-07	Use of bradycardiac substances in the treatment of myocardial diseases associated with hypertrophy and novel medicament combinations

Country Status (33)

Country	Link
US (2)	US7208508B2 (en)
EP (2)	EP1276476B1 (en)
JP (1)	JP3905386B2 (en)
KR (1)	KR20020089453A (en)
CN (1)	CN1245963C (en)
AT (1)	ATE330588T1 (en)
AU (2)	AU7048401A (en)
BG (1)	BG65816B1 (en)
BR (1)	BR0109996A (en)
CA (2)	CA2404120C (en)
CY (1)	CY1105081T1 (en)
CZ (1)	CZ300549B6 (en)
DE (2)	DE10018401A1 (en)
DK (1)	DK1276476T3 (en)
EA (1)	EA006977B1 (en)
EE (1)	EE05099B1 (en)
ES (1)	ES2266216T3 (en)
HR (1)	HRP20020815A2 (en)
HU (1)	HU228387B1 (en)
IL (2)	IL152103A0 (en)
ME (1)	MEP45908A (en)
MX (1)	MXPA02009935A (en)
NO (1)	NO330311B1 (en)
NZ (1)	NZ521934A (en)
PL (1)	PL215235B1 (en)
PT (1)	PT1276476E (en)
RS (1)	RS51478B (en)
SI (1)	SI1276476T1 (en)
SK (1)	SK286075B6 (en)
TR (1)	TR200202326T2 (en)
UA (1)	UA78679C2 (en)
WO (1)	WO2001078699A2 (en)
ZA (1)	ZA200208162B (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE10018401A1 (en)	2000-04-13	2001-10-25	Boehringer Ingelheim Pharma	Medicament for treating hypertrophy-related myocardial disease, containing bradycardic agent, preferably cilobradine, and optionally another cardiac drug
US20040138306A1 (en) *	2002-07-25	2004-07-15	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Use of a specific cyclic amine derivative or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure
PT1362590E (en) *	2002-07-25	2004-05-31	Boehringer Ingelheim Pharma	USE OF CILOBRADINE OR OF ITS PHARMACEUTICALLY ACCEPTABLE SALTS FOR THE TREATMENT OR PREVENTION OF HEART FAILURE
PL377344A1 (en) *	2003-01-31	2006-01-23	Sankyo Company, Limited	Medicine for prevention of and treatment for arteriosclerosis and hypertension
BRPI0612674B8 (en) *	2005-06-27	2021-05-25	Daiichi Sankyo Co Ltd	pharmaceutical preparation, use of an angiotensin ii receptor antagonist and a calcium channel blocker
JPWO2007023775A1 (en) *	2005-08-23	2009-02-26	アステラス製薬株式会社	Atrial fibrillation treatment
EP1762179A1 (en) *	2005-09-07	2007-03-14	Boehringer Ingelheim Vetmedica Gmbh	Method for improving diagnostic quality in echocardiography
FR2894825B1 (en) *	2005-12-21	2010-12-03	Servier Lab	NOVEL ASSOCIATION OF SINUSAL IF CURRENT INHIBITOR AND CONVERSION ENZYME INHIBITOR AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
TWI399223B (en) *	2006-09-15	2013-06-21	Daiichi Sankyo Co Ltd	Solid dosage form of olmesartan and amlodipine
EP1908469A1 (en) *	2006-10-06	2008-04-09	Boehringer Ingelheim Vetmedica Gmbh	Angiotensin II receptor antagonist for the treatment of systemic diseases in cats
MX346039B (en)	2009-05-20	2017-03-03	Boehringer Ingelheim Vetmedica Gmbh	Pharmaceutical oral telmisartan solution.
FR2961105B1 (en)	2010-06-15	2013-02-08	Servier Lab	USE OF THE ASSOCIATION OF A SINUSAL IF CURRENT INHIBITOR AND AN INHIBITOR OF THE ANGIOTENSIN CONVERSION ENZYME FOR THE TREATMENT OF CARDIAC INSUFFICIENCY
KR101296743B1 (en) *	2011-02-17	2013-08-20	한국과학기술연구원	Biomarkers for diagnosing cardiac hypertrophy and method for diagnosis using the same
AR089646A1 (en) *	2011-08-12	2014-09-10	Boehringer Ingelheim Vetmed	FUNNY CURRENT INHIBITORS (IF) TO USE IN A METHOD OF TREATMENT AND PREVENTION OF HEART FAILURE IN FELINOS
WO2014122248A1 (en)	2013-02-11	2014-08-14	Boehringer Ingelheim Vetmedica Gmbh	Kit-of-parts
SI3648761T1 (en)	2017-07-07	2024-07-31	Boehringer Ingelheim Vetmedica Gmbh	Telmisartan for the prophylaxis or treatment of hypertension in cats
KR102331806B1 (en)	2020-07-20	2021-12-01	한림대학교 산학협력단	Biomarker for diagnosis of severe subarachnoid hemorrhage
KR102398532B1 (en)	2020-07-20	2022-05-13	한림대학교 산학협력단	Composition for diagnosis of severe subarachnoid hemorrhage

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BE759125A (en)	1969-11-19	1971-05-18	Boehringer Sohn Ingelheim	NEW N-ALLYL-2-ARYLAMINO-IMIDAZOLINES- (2) SUBSTITUTES AND METHODS FOR MAKING THEM
DE3119874A1 (en)	1981-05-19	1982-12-09	Dr. Karl Thomae Gmbh, 7950 Biberach	"BENZAZEPINE DERIVATIVES, THEIR PRODUCTION AND THEIR USE AS MEDICINAL PRODUCTS"
US5175157A (en)	1985-11-27	1992-12-29	Boehringer Ingelheim Gmbh	Cyclic amine derivatives, pharmaceutical compositions containing these compounds and methods for preparing them
DE3541811A1 (en) *	1985-11-27	1987-06-04	Thomae Gmbh Dr K	NEW CYCLIC AMINE DERIVATIVES, MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF
DE3736866A1 (en)	1987-10-30	1989-05-11	Thomae Gmbh Dr K	MEANS FOR THE TREATMENT OF HYPERTENSION AND HEART FAILURE
DE3805635A1 (en)	1988-02-24	1989-09-07	Thomae Gmbh Dr K	USE OF BENZIMIDAZOLES FOR THE MANUFACTURE OF A MEDICAMENT WITH ANTI-MIXIC EFFECTS ON THE HEART AND ITS COMBINATIONS WITH SS-BLOCKERS OR BRADYCARDICA
US5308853A (en) *	1991-12-20	1994-05-03	Warner-Lambert Company	Substituted-5-methylidene hydantoins with AT1 receptor antagonist properties
RU2078536C1 (en) *	1993-09-02	1997-05-10	Украинский научно-исследовательский институт кардиологии им.акад.Н.Д.Стражеско	Method for evaluating clinical efficiency of using verapamyl and dilthiazem in patients affected with hypertrophic cardiomyopathy
AU692474B2 (en)	1993-09-24	1998-06-11	Procter & Gamble Company, The	Novel deoxy and oxygen-substituted sugar-containing 14-aminosteroid compounds
US5595987A (en) *	1994-07-22	1997-01-21	The Trustees Of Columbia University In The City Of New York	Method of slowing ventricular arrhythmias using zatebradine
US6083991A (en) *	1997-06-04	2000-07-04	University Of Florida Research Foundation, Inc.	Anti-arrhythmic composition and methods of treatment
DE19741635A1 (en)	1997-09-22	1999-03-25	Hoechst Marion Roussel De Gmbh	Biphenylsulfonylcyanamides, process for their preparation and their use as a medicament
DE122007000055I1 (en) *	1998-07-10	2007-12-13	Novartis Pharma Ag	Anti-hypertensive combination of the valsartan and calcium channel blocker
DE10018401A1 (en) *	2000-04-13	2001-10-25	Boehringer Ingelheim Pharma	Medicament for treating hypertrophy-related myocardial disease, containing bradycardic agent, preferably cilobradine, and optionally another cardiac drug
CA2435526A1 (en)	2002-07-25	2004-01-25	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Use of cyclic amine derivatives or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure
US20040138306A1 (en)	2002-07-25	2004-07-15	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Use of a specific cyclic amine derivative or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure
EP1762179A1 (en) *	2005-09-07	2007-03-14	Boehringer Ingelheim Vetmedica Gmbh	Method for improving diagnostic quality in echocardiography

2000
- 2000-04-13 DE DE10018401A patent/DE10018401A1/en not_active Withdrawn
2001
- 2001-04-07 RS YUP-769/02A patent/RS51478B/en unknown
- 2001-04-07 CZ CZ20023752A patent/CZ300549B6/en not_active IP Right Cessation
- 2001-04-07 WO PCT/EP2001/004034 patent/WO2001078699A2/en not_active Ceased
- 2001-04-07 PL PL357827A patent/PL215235B1/en unknown
- 2001-04-07 EA EA200201053A patent/EA006977B1/en not_active IP Right Cessation
- 2001-04-07 HU HU0300917A patent/HU228387B1/en not_active IP Right Cessation
- 2001-04-07 ME MEP-459/08A patent/MEP45908A/en unknown
- 2001-04-07 AT AT01949281T patent/ATE330588T1/en active
- 2001-04-07 MX MXPA02009935A patent/MXPA02009935A/en active IP Right Grant
- 2001-04-07 BR BR0109996-5A patent/BR0109996A/en not_active Application Discontinuation
- 2001-04-07 CA CA002404120A patent/CA2404120C/en not_active Expired - Fee Related
- 2001-04-07 ES ES01949281T patent/ES2266216T3/en not_active Expired - Lifetime
- 2001-04-07 EP EP01949281A patent/EP1276476B1/en not_active Expired - Lifetime
- 2001-04-07 CA CA002575059A patent/CA2575059A1/en not_active Abandoned
- 2001-04-07 DK DK01949281T patent/DK1276476T3/en active
- 2001-04-07 EE EEP200200590A patent/EE05099B1/en not_active IP Right Cessation
- 2001-04-07 DE DE50110262T patent/DE50110262D1/en not_active Expired - Lifetime
- 2001-04-07 US US10/257,481 patent/US7208508B2/en not_active Expired - Fee Related
- 2001-04-07 EP EP06111485A patent/EP1666042A3/en not_active Withdrawn
- 2001-04-07 TR TR2002/02326T patent/TR200202326T2/en unknown
- 2001-04-07 AU AU7048401A patent/AU7048401A/en active Pending
- 2001-04-07 SK SK1458-2002A patent/SK286075B6/en not_active IP Right Cessation
- 2001-04-07 SI SI200130616T patent/SI1276476T1/en unknown
- 2001-04-07 JP JP2001576000A patent/JP3905386B2/en not_active Expired - Fee Related
- 2001-04-07 NZ NZ521934A patent/NZ521934A/en not_active IP Right Cessation
- 2001-04-07 PT PT01949281T patent/PT1276476E/en unknown
- 2001-04-07 AU AU2001270484A patent/AU2001270484B2/en not_active Ceased
- 2001-04-07 IL IL15210301A patent/IL152103A0/en unknown
- 2001-04-07 KR KR1020027013688A patent/KR20020089453A/en not_active Ceased
- 2001-04-07 HR HRP20020815 patent/HRP20020815A2/en not_active Application Discontinuation
- 2001-04-07 CN CNB018079598A patent/CN1245963C/en not_active Expired - Fee Related
- 2001-07-04 UA UA2002118949A patent/UA78679C2/en unknown
2002
- 2002-09-13 BG BG107103A patent/BG65816B1/en unknown
- 2002-10-03 IL IL152103A patent/IL152103A/en not_active IP Right Cessation
- 2002-10-10 ZA ZA200208162A patent/ZA200208162B/en unknown
- 2002-10-11 NO NO20024924A patent/NO330311B1/en not_active IP Right Cessation
2006
- 2006-07-07 CY CY20061100956T patent/CY1105081T1/en unknown
2007
- 2007-03-12 US US11/684,974 patent/US20070155679A1/en not_active Abandoned

Publication	Publication Date	Title
AU775126C (en)	2005-09-01	Substituted oxazolidinones and their use in the field of blood coagulation
AU2001293553A1 (en)	2002-04-02	Phosphatidylserine-carrying apoptosis-mimicking bodies and the use thereof in medical treatment
AU2001270484A1 (en)	2002-01-17	Use of bradycardiac substances in the treatment of myocardial diseases associated with hypertrophy and novel medicament combinations
ZA200300788B (en)	2004-02-19	Improvements in and relating to the use of honey in dressings.
AU3997300A (en)	2000-09-14	Gene sequence variations with utility in determining the treatment of disease
AU2003291609A1 (en)	2004-07-29	Cb 1/cb 2 receptor ligands and their use in the treatment of pain
PL357827A1 (en)	2004-07-26	Use of bradycardiac substances in the treatment of myocardial diseases associated with hypertrophy and novel medicament combinations
AU2001294876A1 (en)	2002-04-08	Direct growth of nanotubes, and their use in nanotweezers
AU2001283285A1 (en)	2002-03-04	Antimicrobial composition and methods of use in the treatment of disease
AU4289100A (en)	2000-10-16	Dihydropyrimidines and their use in the treatment of hepatitis
AU2001233739A1 (en)	2001-10-30	Use of natural substances in the production of cosmetic preparations
AU4923200A (en)	2000-12-18	Isothiazolecarboxamides and their use as microbicides
EE04490B1 (en)	2005-06-15	The compound, its method of preparation and its use in medicine
GB0019302D0 (en)	2000-09-27	Biological materials and the use thereof for the treatment of disease
AU2002354489A1 (en)	2003-06-30	Lumen formation-inducible material and instrument to be inserted into the body
AU5464901A (en)	2001-09-12	Dichloropyridyl- and dichloroisothiazolyl-thiocarboxamides and their use as microbicides
AU2001253886A1 (en)	2001-10-30	Methylxanthines in the diagnosis and treatment of autistic disorder
AU2001252627A1 (en)	2002-01-31	Polybenzasol fiber and use of the same
AU2003244455A1 (en)	2003-09-02	Piperidylcarboxamide derivatives and their use in the treatment of tachykinim-mediated diseases
GB0007217D0 (en)	2000-05-17	Materials and methods relating to the treatment of leukaemias
AU2003270350A1 (en)	2004-03-29	Isoxazoles and their use in the treatment of ischemic diseases
AU2002210763A1 (en)	2002-05-15	Use of 1-ebio in the treatment of bipolar disorders
AU5020700A (en)	2000-12-18	Treating allergic diseases with immunotherapy and ige antagonists
AU2003244437A1 (en)	2003-09-02	Quinoxalinones and their use especially in the treatment of cardiovascular diseases
AU2001223910A1 (en)	2001-07-31	Interferon-alpha use in the treatment of ewing's family of tumors